Trials / Completed
CompletedNCT03773042
A Study Evaluating Tolerability, Efficacy, and Safety of HSK3486 Injectable Emulsion in Patients
A Phase IIa, Multi-center, Open-label, Non-randomized, Active-controlled, and Dose-escalation Clinical Study Evaluating Tolerability, Efficacy, and Safety of HSK3486 Injectable Emulsion for Sedation/Anesthesia in Patients Undergoing Diagnostic Colonoscopy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Sichuan Haisco Pharmaceutical Group Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
A double-blind, randomized, active controlled, multi-center, parallel group study comparing HSK3486 with Propofol, in patients undergoing a colonoscopy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HSK3486 | For induction and maintenance of sedation. |
| DRUG | Propofol | For induction and maintenance of sedation. |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2017-06-01
- Completion
- 2017-06-01
- First posted
- 2018-12-12
- Last updated
- 2018-12-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03773042. Inclusion in this directory is not an endorsement.